For ALS we are proud to partner with TRICALS, the largest European research initiative to find a cure and effective treatments for ALS. TRICALS is a collaboration of over 40 top research centers in 15 countries who have joined hands with patient organisations and fundraisers. All the TRICALS sites are large and specialised, with an excellent track record in both pharma and investigator-initiated clinical trials, which deliver rapid and on target participant recruitment and high-quality outcome data.
The TRICALS and Julius Clinical partnership combines operational excellence, a trial-ready infrastructure and leading experts, allowing for
- State-of-the-art and smart clinical trial design and oversight
- High quality clinical trial execution
- Effective subject recruitment
- Scientific publication & communication
Click here for more information about TRICALS.